Contact Us

Wilbert Solomon Aronow, MD, Presented with the Albert Nelson Marquis Lifetime Achievement Award by Marquis Who's Who

Dr. Aronow has been endorsed by Marquis Who's Who as a leader in the health care and education industries
  • <strong>Wilbert Solomon Aronow, MD</strong>
    NEW ROCHELLE, NY, October 06, 2017 /24-7PressRelease/ -- Marquis Who's Who, the world's premier publisher of biographical profiles, is proud to present Wilbert Solomon Aronow, MD, with the Albert Nelson Marquis Lifetime Achievement Award. An accomplished listee, Dr. Aronow celebrates many years' experience in his professional network, and has been noted for achievements, leadership qualities, and the credentials and successes he has accrued in his field. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.

Drawing upon more than 60 years of medical experience, Dr. Aronow serves as a professor of medicine and director of cardiology research at the Westchester Medical Center and New York Medical College. He is a widely renowned expert in cardiovascular disease, with specific focus on the effects of air pollution, active smoking and passive smoking on cardiovascular disease, cardiovascular drugs, cardiovascular disease in the elderly, and the diagnosis and treatment of coronary heart disease. He has also focused his practice on peripheral arterial disease, stroke, heart failure, valvular heart disease, atrial fibrillation, ventricular arrhythmias, cardiomyopathies, diabetes mellitus, hypertension and lipid disorders.

Throughout the course of his career, Dr. Aronow has authored or co-authored more than 1,594 papers, 475 commentaries and 1,074 abstracts in his fields of expertise. Additionally, he has served as a presenter or co-presenter at more than 1,400 talks at meetings. A recognized authority in his fields of expertise, Dr. Aronow has been a member of 160 editorial boards of medical journals, editor-in-chief of four journals, co-editor of two journals, deputy editor of one journal, executive editor of two journals, associate editor of nine journals and guest editor for seven other medical journals. At the present moment, he is editing his sixteenth book, the sixth edition of "Cardiovascular Disease in the Elderly."

In recognition of his commitment to health care, medical research and education, Dr. Aronow has been featured in a wide range of honors publications, including Who's Who in America, Who's Who in American Education, Who's Who in Medicine and Healthcare, Who's Who in Science and Engineering, Who's Who in the East and Who's Who in the World. He has received numerous awards for teaching and research, including the Distinguished Service Award from the Society for Geriatric Cardiology in 2003, Joseph T. Freeman Award from the GSA in 2005, Walter Bleifeld Memorial Award for distinguished contributions to clinical research from the International Academy of Cardiology in 2010, and a Distinguished Fellowship Award from the International Academy of Cardiology in 2012.

Dr. Aronow is a recognized fellow of the American College of Cardiology, American Heart Association, American College of Physicians, American College of Chest Physicians, American Society of Preventative Cardiology, American Geriatrics Society and Gerontological Society of America. In previous positions, he served as a member of national committees and as a reviewer of national guidelines. Dr. Aronow is credited as the co-author of the 2010 American Medical Directors Association guidelines for heart failure, co-chair and first author of the ACC/AHA expert consensus document on hypertension in the elderly, and co-author of the 2015 AHA/ACC/ASH scientific statement on treatment of hypertension in patients with coronary artery disease. He is currently a member of the writing group of the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guidelines for the management of patients with hypertension, which will be published in 2017.

Prior to pursuing a career in medicine, Dr. Aronow attended Queens College, where he received a Bachelor of Science in 1953. He went on to complete an MD at Harvard University in 1957, as well as an internship and residency at the Michael Reese Hospital and Medical Center between 1957 and 1961. Certified through the American Board of Internal Medicine, Dr. Aronow served to the rank of captain with the U.S. Army Medical Corps.

In recognition of outstanding contributions to his profession and the Marquis Who's Who community, Wilbert Solomon Aronow, MD, has been featured on the Albert Nelson Marquis Lifetime Achievement website. Please visit www.ltachievers.com for more information about this honor.

About Marquis Who's Who :
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America , Marquis Who's Who has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Today, Who's Who in America remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. Marquis publications may be visited at the official Marquis Who's Who website at www.marquiswhoswho.com.


# # #

Read more Press Releases from Fred Marks:


Comment on this story...

Share This Story


Email this Story

Contact Information


Fred Marks
Marquis Who's Who Ventures LLC

Berkeley Heights, NJ
USA
Voice: 844-394-6946
E-Mail: Email Us Here
Website: Visit Our Website
Follow Us:

Like This Story?


I like it! 0

Disclaimer


If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7 Press Release Newswire. We are unable to assist you with any information regarding this release. 24-7 Press Release Newswire disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.